• About
  • Contact
  • Resources
  • Book Nook
Donate
  • Featured
  • Commentary
  • Science & News
  • Mainstream
    • Mainstream Prevention
    • Mainstream Treatment
    • Vaccines
    • Repurposed Drugs
  • Integrative
    • Integrative Prevention
    • Integrative Treatments
    • Integrative Recovery
      • Long Haul
  • Controversies
    • Ivermectin
  • Blog
    • Michael Lerner’s Blog
    • Guest Authors
MenuClose
  • Featured
  • Commentary
  • Science & News
  • Mainstream Solutions
    • Mainstream Prevention
    • Mainstream Treatment
    • Vaccines
    • Repurposed Drugs
  • Integrative Therapies
    • Integrative Prevention
    • Integrative Treatments
    • Integrative Recovery
      • Long Haul
  • Controversies
    • Ivermectin
  • Blog
    • Guest Authors
    • Michael Lerner’s Blog
  • About
  • Contact
  • Resources
  • Donate

Laith J. Abu-Raddad


Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections

Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections

by Covid Strategies | Nov 24, 2021 | Commentary

This letter was published on November 24, 2021, at NEJM.org. TO THE EDITOR: Qatar had a first wave of infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from March through June 2020, after which approximately 40% of the population had...

read more
SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy

SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy

by Covid Strategies | Jul 31, 2021 | Science & News

Published in EClinicalMedicine by The Lancet ~ May 1, 2021 ~ by Laith J. Abu-Raddad, et al. Abstract Background Reinfection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been documented, raising public health concerns. SARS-CoV-2...

read more

Address:

Commonweal P.O Box 316 | Bolinas, CA 94924

Latest Covid news in your inbox!

Success!

Subscribe

Search Articles

©2021 CovidStrategies/Commonweal | Site maintained by Mercury Multimedia

Privacy Policy | Home